EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welt, C.
Right arrow Articles by Schneyer, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welt, C.
Right arrow Articles by Schneyer, A.
Experimental Biology and Medicine 227:724-752 (2002)
© 2002 Society for Experimental Biology and Medicine


MINIREVIEW

Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium

Corrine Welt*, Yisrael Sidis*, Henry Keutmann{dagger} and Alan Schneyer*,1

* Reproductive Endocrine Unit and
{dagger} Endocrine Unit, Massachusetts General Hospital, Boston, Massachussetts 02114

It has been 70 years since the name inhibin was used to describe a gonadal factor that negatively regulated pituitary hormone secretion. The majority of this period was required to achieve purification and definitive characterization of inhibin, an event closely followed by identification and characterization of activin and follistatin (FS). In contrast, the last 15–20 years saw a virtual explosion of information regarding the biochemistry, physiology, and biosynthesis of these proteins, as well as identification of activin receptors, and a unique mechanism for FS action—the nearly irreversible binding and neutralization of activin. Many of these discoveries have been previously summarized; therefore, this review will cover the period from the mid 1990s to present, with particular emphasis on emerging themes and recent advances. As the field has matured, recent efforts have focused more on human studies, so the endocrinology of inhibin, activin, and FS in the human is summarized first. Another area receiving significant recent attention is local actions of activin and its regulation by both FS and inhibin. Because activin and FS are produced in many tissues, we chose to focus on a few particular examples with the most extensive experimental support, the pituitary and the developing follicle, although nonreproductive actions of activin and FS are also discussed. At the cellular level, it now seems that activin acts largely as an autocrine and/or paracrine growth factor, similar to other members of the transforming growh factor ß superfamily. As we discuss in the next section, its actions are regulated extracellularly by both inhibin and FS. In the final section, intracellular mediators and modulators of activin signaling are reviewed in detail. Many of these are shared with other transforming growh factor ß superfamily members as well as unrelated molecules, and in a number of cases, their physiological relevance to activin signal propagation remains to be elucidated. Nevertheless, taken together, recent findings suggest that it may be more appropriate to consider a new paradigm for inhibin, activin, and FS in which activin signaling is regulated extracellularly by both inhibin and FS whereas a number of intracellular proteins act to modulate cellular responses to these activin signals. It is therefore the balance between activin and all of its modulators, rather than the actions of any one component, that determines the final biological outcome. As technology and model systems become more sophisticated in the next few years, it should become possible to test this concept directly to more clearly define the role of activin, inhibin, and FS in reproductive physiology.

Key Words: activin • inhibin • follistatin • follistatin-related protein • FSRP/FLRG • transforming growth factor ß • SMADs • activin receptors • signaling • endocrinology • paracrine actions • autocrine actions




This article has been cited by other articles:


Home page
J EndocrinolHome page
Y. Xia and A. L Schneyer
The biology of activin: recent advances in structure, regulation and function
J. Endocrinol., July 1, 2009; 202(1): 1 - 12.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. F. Medeiros, M. P. Phelps, F. D. Fuentes, and T. M. Bradley
Overexpression of follistatin in trout stimulates increased muscling
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2009; 297(1): R235 - R242.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Blount, K. Schmidt, N. J. Justice, W. W. Vale, W. H. Fischer, and L. M. Bilezikjian
FoxL2 and Smad3 Coordinately Regulate Follistatin Gene Transcription
J. Biol. Chem., March 20, 2009; 284(12): 7631 - 7645.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Singh, S. Bhasin, M. Braga, J. N. Artaza, S. Pervin, W. E. Taylor, V. Krishnan, S. K. Sinha, T. B. Rajavashisth, and R. Jasuja
Regulation of Myogenic Differentiation by Androgens: Cross Talk between Androgen Receptor/ {beta}-Catenin and Follistatin/Transforming Growth Factor-{beta} Signaling Pathways
Endocrinology, March 1, 2009; 150(3): 1259 - 1268.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Stamler, H. T. Keutmann, Y. Sidis, C. Kattamuri, A. Schneyer, and T. B. Thompson
The Structure of FSTL3{middle dot}Activin A Complex: DIFFERENTIAL BINDING OF N-TERMINAL DOMAINS INFLUENCES FOLLISTATIN-TYPE ANTAGONIST SPECIFICITY
J. Biol. Chem., November 21, 2008; 283(47): 32831 - 32838.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. M. Necela, W. Su, and E. A. Thompson
Peroxisome Proliferator-activated Receptor {gamma} Down-regulates Follistatin in Intestinal Epithelial Cells through SP1
J. Biol. Chem., October 31, 2008; 283(44): 29784 - 29794.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. R. Sowers, H. Zheng, D. McConnell, B. Nan, S. Harlow, and J. F. Randolph Jr.
Follicle Stimulating Hormone and Its Rate of Change in Defining Menopause Transition Stages
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3958 - 3964.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. R. Sowers, A. D. Eyvazzadeh, D. McConnell, M. Yosef, M. L. Jannausch, D. Zhang, S. Harlow, and J. F. Randolph Jr.
Anti-Mullerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause Transition
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3478 - 3483.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. L. Schneyer, Y. Sidis, A. Gulati, J. L. Sun, H. Keutmann, and P. A. Krasney
Differential Antagonism of Activin, Myostatin and Growth and Differentiation Factor 11 by Wild-Type and Mutant Follistatin
Endocrinology, September 1, 2008; 149(9): 4589 - 4595.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. Veiga-Lopez, W. Ye, D.J. Phillips, C. Herkimer, P.G. Knight, and V. Padmanabhan
Developmental Programming: Deficits in Reproductive Hormone Dynamics and Ovulatory Outcomes in Prenatal, Testosterone-Treated Sheep
Biol Reprod, April 1, 2008; 78(4): 636 - 647.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Blount, J. M. Vaughan, W. W. Vale, and L. M. Bilezikjian
A Smad-binding Element in Intron 1 Participates in Activin-dependent Regulation of the Follistatin Gene
J. Biol. Chem., March 14, 2008; 283(11): 7016 - 7026.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
K. Hayashi, A. R O'Connell, J. L Juengel, K. P McNatty, G. H Davis, F. W Bazer, and T. E Spencer
Postnatal uterine development in Inverdale ewe lambs
Reproduction, March 1, 2008; 135(3): 357 - 365.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J. M Young, J. L Juengel, K. G Dodds, M. Laird, P. K Dearden, A. S McNeilly, K. P McNatty, and T. Wilson
The activin receptor-like kinase 6 Booroola mutation enhances suppressive effects of bone morphogenetic protein 2 (BMP2), BMP4, BMP6 and growth and differentiation factor-9 on FSH release from ovine primary pituitary cell cultures
J. Endocrinol., February 1, 2008; 196(2): 251 - 261.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S.-Y. Lin, R. G. Craythorn, A. E. O'Connor, M. M. Matzuk, J. E. Girling, J. R. Morrison, and D. M. de Kretser
Female Infertility and Disrupted Angiogenesis Are Actions of Specific Follistatin Isoforms
Mol. Endocrinol., February 1, 2008; 22(2): 415 - 429.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
G. F Y Cheng, C.-W. Yuen, and W. Ge
Evidence for the existence of a local activin follistatin negative feedback loop in the goldfish pituitary and its regulation by activin and gonadal steroids
J. Endocrinol., December 1, 2007; 195(3): 373 - 384.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. G. Farnworth, Y. Wang, R. Escalona, P. Leembruggen, G. T. Ooi, and J. K. Findlay
Transforming Growth Factor-{beta} Blocks Inhibin Binding to Different Target Cell Types in a Context-Dependent Manner through Dual Mechanisms Involving Betaglycan
Endocrinology, November 1, 2007; 148(11): 5355 - 5368.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Myers, E. Gay, A. S. McNeilly, H. M. Fraser, and W. C. Duncan
In Vitro Evidence Suggests Activin-A May Promote Tissue Remodeling Associated with Human Luteolysis
Endocrinology, August 1, 2007; 148(8): 3730 - 3739.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
W. Zheng, M. Jimenez-Linan, B. S. Rubin, and L. M. Halvorson
Anterior Pituitary Gene Expression with Reproductive Aging in the Female Rat
Biol Reprod, June 1, 2007; 76(6): 1091 - 1102.
[Abstract] [Full Text] [PDF]


Home page
Poult. Sci.Home page
J. B. Hoffman, A. P. Benson, V. L. Christensen, B. D. Fairchild, and A. J. Davis
Follicular Development and Expression of the Messenger Ribonucleic Acid for the Inhibin/Activin Subunits in Two Genetic Lines of Turkey Hens that Differ in Total Egg Production
Poult. Sci., May 1, 2007; 86(5): 944 - 952.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Mukherjee, Y. Sidis, A. Mahan, M. J. Raher, Y. Xia, E. D. Rosen, K. D. Bloch, M. K. Thomas, and A. L. Schneyer
FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults
PNAS, January 23, 2007; 104(4): 1348 - 1353.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. C. Gray, G. Shani, K. Aung, J. Kelber, and W. Vale
Cripto Binds Transforming Growth Factor {beta} (TGF-{beta}) and Inhibits TGF-{beta} Signaling
Mol. Cell. Biol., December 15, 2006; 26(24): 9268 - 9278.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
K.R. Barnett, C. Schilling, C.R. Greenfeld, D. Tomic, and J.A. Flaws
Ovarian follicle development and transgenic mouse models
Hum. Reprod. Update, September 1, 2006; 12(5): 537 - 555.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
L. M Bilezikjian, A. L Blount, C. J Donaldson, and W. W Vale
Pituitary actions of ligands of the TGF-{beta} family: activins and inhibins.
Reproduction, August 1, 2006; 132(2): 207 - 215.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Sidis, A. Mukherjee, H. Keutmann, A. Delbaere, M. Sadatsuki, and A. Schneyer
Biological Activity of Follistatin Isoforms and Follistatin-Like-3 Is Dependent on Differential Cell Surface Binding and Specificity for Activin, Myostatin, and Bone Morphogenetic Proteins
Endocrinology, July 1, 2006; 147(7): 3586 - 3597.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y.-G. Chen, Q. Wang, S.-L. Lin, C. D. Chang, J. Chung, and S.-Y. Ying
Activin Signaling and Its Role in Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis.
Experimental Biology and Medicine, May 1, 2006; 231(5): 534 - 544.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. H.-C. Yao, J. Aardema, and K. Holthusen
Sexually Dimorphic Regulation of Inhibin Beta B in Establishing Gonadal Vasculature in Mice
Biol Reprod, May 1, 2006; 74(5): 978 - 983.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
P. Lamba, M. M Santos, D. P Philips, and D. J Bernard
Acute regulation of murine follicle-stimulating hormone {beta} subunit transcription by activin A
J. Mol. Endocrinol., February 1, 2006; 36(1): 201 - 220.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
C. Glister, N. P Groome, and P. G Knight
Bovine follicle development is associated with divergent changes in activin-A, inhibin-A and follistatin and the relative abundance of different follistatin isoforms in follicular fluid
J. Endocrinol., February 1, 2006; 188(2): 215 - 225.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Patella, D. J. Phillips, J. Tchongue, D. M. de Kretser, and W. Sievert
Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis
Am J Physiol Gastrointest Liver Physiol, January 1, 2006; 290(1): G137 - G144.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. R. Kumar
Too Many Follistatins: Racing Inside and Getting Out of the Cell
Endocrinology, December 1, 2005; 146(12): 5048 - 5051.
[Full Text] [PDF]


Home page
EndocrinologyHome page
S. Saito, Y. Sidis, A. Mukherjee, Y. Xia, and A. Schneyer
Differential Biosynthesis and Intracellular Transport of Follistatin Isoforms and Follistatin-Like-3
Endocrinology, December 1, 2005; 146(12): 5052 - 5062.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, A. E. Taylor, J. Fox, G. M. Messerlian, J. M. Adams, and A. L. Schneyer
Follicular Arrest in Polycystic Ovary Syndrome Is Associated with Deficient Inhibin A and B Biosynthesis
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5582 - 5587.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. R. Greb, K. Grieshaber, J. Gromoll, B. Sonntag, E. Nieschlag, L. Kiesel, and M. Simoni
A Common Single Nucleotide Polymorphism in Exon 10 of the Human Follicle Stimulating Hormone Receptor Is a Major Determinant of Length and Hormonal Dynamics of the Menstrual Cycle
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4866 - 4872.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Xia, Y. Sidis, A. Mukherjee, T. A. Samad, G. Brenner, C. J. Woolf, H. Y. Lin, and A. Schneyer
Localization and Action of Dragon (Repulsive Guidance Molecule b), a Novel Bone Morphogenetic Protein Coreceptor, throughout the Reproductive Axis
Endocrinology, August 1, 2005; 146(8): 3614 - 3621.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. Ndiaye, T. Fayad, D. W. Silversides, J. Sirois, and J. G. Lussier
Identification of Downregulated Messenger RNAs in Bovine Granulosa Cells of Dominant Follicles Following Stimulation with Human Chorionic Gonadotropin
Biol Reprod, August 1, 2005; 73(2): 324 - 333.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. D. Cherrington, T. A. Farmerie, C. A. Lents, J. D. Cantlon, M. S. Roberson, and C. M. Clay
Activin Responsiveness of the Murine Gonadotropin-Releasing Hormone Receptor Gene Is Mediated by a Composite Enhancer Containing Spatially Distinct Regulatory Elements
Mol. Endocrinol., April 1, 2005; 19(4): 898 - 912.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
J.L. Juengel and K.P. McNatty
The role of proteins of the transforming growth factor-{beta} superfamily in the intraovarian regulation of follicular development
Hum. Reprod. Update, March 1, 2005; 11(2): 144 - 161.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. J. Gregory, C. T. Lacza, A. A. Detz, S. Xu, L. A. Petrillo, and U. B. Kaiser
Synergy between Activin A and Gonadotropin-Releasing Hormone in Transcriptional Activation of the Rat Follicle-Stimulating Hormone-{beta} Gene
Mol. Endocrinol., January 1, 2005; 19(1): 237 - 254.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Sidis, A. L. Schneyer, and H. T. Keutmann
Heparin and Activin-Binding Determinants in Follistatin and FSTL3
Endocrinology, January 1, 2005; 146(1): 130 - 136.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. del Re, Y. Sidis, D. A. Fabrizio, H. Y. Lin, and A. Schneyer
Reconstitution and Analysis of Soluble Inhibin and Activin Receptor Complexes in a Cell-free System
J. Biol. Chem., December 17, 2004; 279(51): 53126 - 53135.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. E. West, G. E. Parker, J. J. Savage, P. Kiratipranon, K. S. Toomey, L. R. Beach, S. C. Colvin, K. W. Sloop, and S. J. Rhodes
Regulation of the Follicle-Stimulating Hormone {beta} Gene by the LHX3 LIM-Homeodomain Transcription Factor
Endocrinology, November 1, 2004; 145(11): 4866 - 4879.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Utomo, X. Jiang, S. Furuta, J. Yun, D. S. Levin, Y.-C. J. Wang, K. V. Desai, J. E. Green, P.-L. Chen, and W.-H. Lee
Identification of a Novel Putative Non-selenocysteine Containing Phospholipid Hydroperoxide Glutathione Peroxidase (NPGPx) Essential for Alleviating Oxidative Stress Generated from Polyunsaturated Fatty Acids in Breast Cancer Cells
J. Biol. Chem., October 15, 2004; 279(42): 43522 - 43529.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. L. Schneyer, Q. Wang, Y. Sidis, and P. M. Sluss
Differential Distribution of Follistatin Isoforms: Application of a New FS315-Specific Immunoassay
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5067 - 5075.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. Tomic, K. P. Miller, H. A. Kenny, T. K. Woodruff, P. Hoyer, and J. A. Flaws
Ovarian Follicle Development Requires Smad3
Mol. Endocrinol., September 1, 2004; 18(9): 2224 - 2240.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. M. Foster, P. R. Olton, M. S. Racine, D. J. Phillips, and V. Padmanabhan
Sex differences in FSH-regulatory peptides in pubertal age boys and girls and effects of sex steroid treatment
Hum. Reprod., July 1, 2004; 19(7): 1668 - 1676.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. Wada, H. Kuwano, Y. Hasegawa, and I. Kojima
The Dependence of Transforming Growth Factor-{beta}-Induced Collagen Production on Autocrine Factor Activin A in Hepatic Stellate Cells
Endocrinology, June 1, 2004; 145(6): 2753 - 2759.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. J. Jorgez, M. Klysik, S. P. Jamin, R. R. Behringer, and M. M. Matzuk
Granulosa Cell-Specific Inactivation of Follistatin Causes Female Fertility Defects
Mol. Endocrinol., April 1, 2004; 18(4): 953 - 967.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Xia, Y. Sidis, and A. Schneyer
Overexpression of Follistatin-Like 3 in Gonads Causes Defects in Gonadal Development and Function in Transgenic Mice
Mol. Endocrinol., April 1, 2004; 18(4): 979 - 994.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. T. Keutmann, A. L. Schneyer, and Y. Sidis
The Role of Follistatin Domains in Follistatin Biological Action
Mol. Endocrinol., January 1, 2004; 18(1): 228 - 240.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. P. Brothers, J. A. Janovick, and P. M. Conn
Unexpected Effects of Epitope and Chimeric Tags on Gonadotropin-Releasing Hormone Receptors: Implications for Understanding the Molecular Etiology of Hypogonadotropic Hypogonadism
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6107 - 6112.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. Hayashi, K. D. Carpenter, C. A. Gray, and T. E. Spencer
The Activin-Follistatin System in the Neonatal Ovine Uterus
Biol Reprod, September 1, 2003; 69(3): 843 - 850.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. D. Carpenter, K. Hayashi, and T. E. Spencer
Ovarian Regulation of Endometrial Gland Morphogenesis and Activin-Follistatin System in the Neonatal Ovine Uterus
Biol Reprod, September 1, 2003; 69(3): 851 - 860.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
J. E. Buster
Activins, Inhibins, and Follistatins in Reproduction
Reproductive Sciences, May 1, 2003; 10(4): 177 - 177.
[PDF]


Home page
EndocrinologyHome page
A. Schneyer, A. Schoen, A. Quigg, and Y. Sidis
Differential Binding and Neutralization of Activins A and B by Follistatin and Follistatin Like-3 (FSTL-3/FSRP/FLRG)
Endocrinology, May 1, 2003; 144(5): 1671 - 1674.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Y. Bedecarrats and U. B. Kaiser
Differential Regulation of Gonadotropin Subunit Gene Promoter Activity by Pulsatile Gonadotropin-Releasing Hormone (GnRH) in Perifused L{beta}T2 Cells: Role of GnRH Receptor Concentration
Endocrinology, May 1, 2003; 144(5): 1802 - 1811.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Krishnan, C. Murdock, J. Allard, M. Cisar, E. Reid, L. Nieman, and J. Segars
Pseudo-isolated FSH deficiency caused by an inhibin B-secreting granulosa cell tumour: Case report
Hum. Reprod., March 1, 2003; 18(3): 502 - 505.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Experimental Biology and Medicine.